Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma

Ann Hematol. 2019 Aug;98(8):2013-2015. doi: 10.1007/s00277-019-03663-5. Epub 2019 Mar 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Busulfan / administration & dosage
  • Busulfan / therapeutic use*
  • Drug Evaluation
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Melphalan / administration & dosage
  • Melphalan / therapeutic use*
  • Multiple Myeloma / therapy*
  • Progression-Free Survival
  • Transplantation Conditioning / methods*
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Busulfan
  • Melphalan